PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 8, 2026European Stroke Journal0 citations

Abstract Number: Esoc2026a2364 Balloon Guide Catheter Use Is Associated With Improved Clinical and Angiographic Outcomes in Mechanical Thrombectomy: A Post-Hoc Analysis of the Prost Randomized Trial

View Full Paper
ESEdgar SamaniegoDLDonald LobsienMDMohamed Fahmy Doheim

Key Points

  • To evaluate the impact of balloon guide catheter (BGC) use on clinical and angiographic outcomes during mechanical thrombectomy in the PROST trial.
  • Post-hoc analysis of the PROST trial comparing BGC (n=152) to non-BGC (n=170) in patients with large vessel occlusion stroke.
  • Primary outcome measured was 90-day functional independence (mRS 0-2) and secondary outcomes included first-pass effect, complete reperfusion, and 90-day mortality.
  • Multivariable logistic regression was used to adjust for confounding factors.
  • BGC use resulted in higher rates of 90-day functional independence (63.2% vs 45.3%; OR 2.07, 95% CI 1.32-3.24; p=0.002).
  • Patients with BGC exhibited superior first-pass effect rates (51.7% vs 36.3%; OR 1.87, 95% CI 1.20-2.93; p=0.007).
  • 90-day mortality was lower in the BGC group (9.2% vs 18.2%; OR 0.45, 95% CI 0.23-0.89; p=0.024).

Abstract

Abstract Background and aims Balloon guide catheters (BGC) provide proximal flow arrest during mechanical thrombectomy (MT), potentially improving thrombus retrieval efficiency and reducing distal embolization. However, prospective randomized data comparing BGC versus non-BGC approaches remain limited. We analyzed the impact of BGC use on clinical and angiographic outcomes in the PROST trial. Methods PROST was a multicenter, prospective, randomized trial comparing pRESET versus Solitaire stent retrievers in patients with large vessel occlusion stroke (NCT04102046). In this post-hoc analysis, we compared patients treated with BGC (n=152) versus non-BGC (n=170). The primary outcome was 90-day functional independence (modified Rankin Scale mRS 0-2). Secondary outcomes included first-pass effect (FPE; expanded TICI eTICI ≥2c), complete reperfusion (eTICI ≥2c), and 90-day mortality. Multivariable logistic regression adjusted for age, sex, baseline NIHSS, comorbidities, IV tPA, and anesthesia type. Results Of 322 patients with BGC data, baseline characteristics were balanced between groups (median age 71vs74 years,p=0.11). BGC use was associated with significantly higher rates of 90-day functional independence (63.2% vs 45.3%; OR2.07, 95% CI1.32-3.24;p=0.002). BGC patients demonstrated superior FPE (51.7%vs36.3%;OR1.87,95%CI1.20-2.93;p=0.007). Mortality at 90 days was significantly lower with BGC (9.2% vs 18.2%;OR 0.45,95%CI0.23-0.89;p=0.024). No difference was observed in symptomatic intracranial hemorrhage or embolization to new territory. After multivariable adjustment, BGC remained independently associated with functional independence (adjusted OR1.74,95%CI1.02-3.06). Conclusions In this post-hoc analysis of the PROST trial, BGC use was associated with significantly improved functional outcomes, higher first-pass and complete reperfusion rates, and reduced mortality compared to non-BGC approaches. Conflict of interest None

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Samaniego et al. (2026) studied this question.

synapsesocial.com/papers/69fd7eb0bfa21ec5bbf06e58https://doi.org/10.1093/esj/aakag023.1086
Ask AI
Helpful
Bookmark
Share
View Full Paper